# HERBALIFE LTD. (HLF) · Edgar & Edgarette company card

> Herbalife (HLF) grew revenue 0.9% in FY2025 to $5.0 billion, operating margin 9.5% against a 1.4% median for drugs, proprietaries & druggists' sundries, equity -18.5% of assets, and its dividend per share fell in the latest year on record. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1180262 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HLF) · [JSON](https://www.pops4.com/boards/company/HLF.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $5.0B |
| Revenue growth, 1 year | 0.9% |
| Revenue growth per year | -3.5% |
| Operating margin | 9.5% (prior year 7.7%) |
| Net margin | 4.5% |
| Operating cash flow | $333M |
| Capital spending | $80M |
| Free cash flow | $253M |
| Cash | $353M |
| Long-term debt | $2.0B |
| Total assets | $2.8B |
| Total equity | −$515M |
| Equity ÷ assets | -18.5% |
| Return on equity | — |
| Dividend per share | $0.3 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 0.63 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Weathered boat · two warning signs · filed debt accelerated or triggered in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress)
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $5.0B (FY2025), total debt $2.0B. Experience: revenue up 0.9% on the year, down 3.5% a year over 4 years; operating margin 9.5%, up from 7.7%. Soundness: equity -18.5% of assets (liabilities exceed assets), the dividend per share fell in the latest year on record. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $4.5B and $5.4B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $4.1B to $5.8B. A statistical range, not company guidance. Against peers (30 filers, $50M+ revenue, its industry group): operating margin 9.5% against a 1.4% median; growth 0.9% against 0.9%.

Range logged 2026-10-30, receipt 0e755dd08452497f, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 2.04 Debt accelerated or triggered: 1, latest 2026-05-01 ([filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026051010/0001213900-26-051010-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-08-31 ([filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026095328/0001213900-26-095328-index.htm))

## Recent filings

- 8-K · filed 2026-11-02 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026114951/0001213900-26-114951-index.htm)
- 10-Q · filed 2026-11-02 · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000119312526443675/0001193125-26-443675-index.htm)
- 8-K · filed 2026-08-31 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026095328/0001213900-26-095328-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026085702/0001213900-26-085702-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000119312526335172/0001193125-26-335172-index.htm)
- 8-K · filed 2026-05-06 · 2.02 Results of Operations and Financial Condition; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1180262/000121390026052833/0001213900-26-052833-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001180262.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1180262

## Cite

POPS4, Edgar & Edgarette: HERBALIFE LTD. (HLF) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/HLF. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.